Category: Cosmetics

As global trade dynamics continue to shift, customs brokers, international suppliers to the U.S., and importers must stay ahead of critical regulatory and policy changes that directly impact compliance and operations. From the evolving enforcement priorities at the U.S. Food and Drug Administration (FDA) to renewed scrutiny of de minimis thresholds and tariff policy under

In this webinar, we will provide an overview of Regulation (EC) No. 1223/2009, the mandatory regulation required to market cosmetic products in the European Union and the basis for UK Cosmetics Regulation. This regulation ensures that all cosmetic products are safe for consumers, properly labeled, and manufactured under quality standards. Join us to learn how

This webinar will go into detail about adverse event requirements under the Modernization of Cosmetics Regulations Act (MoCRA) and how important it is for brands and manufacturers to work together to maintain compliance. We will discuss how retailers are aligning with MoCRA’s regulations and asking brands to have a proper system in place to receive,

Learn about the labeling requirements mandated by MoCRA as well as the general requirements all cosmetic products must meet. We will describe in detail what must appear on your products’ labels and the timelines for compliance. Topics include:   Meeting the new adverse event contact requirements FDA actions on fragrance allergens Bilingual labeling requirements

The United States regulates the import of all cosmetics, including over-the-counter (OTC) drug products. The agency responsible for enforcing the various requirements is the US Food and Drug Administration (US FDA). The United States recently enacted the Modernization of Cosmetic Regulations Act of 2022 (MoCRA), which significantly expands the regulatory authority of the U.S. Food and Drug

Booth #: 871

Since 2020, FDA has imposed more requirements on the drug industry. Besides establishment registrations and product listing that have been required for decades, fees are now collected by the FDA on more manufacturers on an annual basis. Amounts of listed drug products are now required to be reported on an annual basis. Stay out of

Chiara Remonti, Senior Regulatory Advisor of Registrar Corp will walk you through key provisions of MoCRA, highlighting how they impact your business operations, and what you need to do before Miami. We’ll cover challenges like product listings, navigating FDA’s Cosmetics Direct portal, adverse event reporting requirements, labeling impacts, and more.

With the MoCRA regulations now in full effect, staying compliant with the latest US FDA cosmetic industry standards is more crucial than ever. Join us for “Practical Steps to be MoCRA Compliant Quickly,” where we will equip cosmetic brands and manufacturers with the knowledge and strategies needed to navigate the evolving regulatory landscape in 2024

Booth #: F21

Booth number: 518

Learn about the labeling requirements mandated by MoCRA as well as the general requirements all cosmetic products must meet. We describe in detail what must appear on your products’ labels and the timelines for compliance. Topics include:   Meeting the new adverse event contact requirements FDA actions on fragrance allergens Bilingual labeling requirements

Booth #: Pending

In this webinar we will take you through retailer’s expectations of MoCRA compliance and how you can continue to stay compliant not to disrupt your supply chain and distribution. What You Can Expert to Learn from This Webinar: Understanding Retailers indirect role in MoCRA Overview of Large Retailers expectations of brands compliance What documentation should be

With the enforcement of MoCRA, becoming and staying compliant with new US FDA cosmetic industry regulations has never been more critical. Join us for “Practical Steps to be MoCRA Compliant Quickly” where we will empower cosmetic brands and manufacturers with knowledge and strategies to navigate the regulatory landscape in 2024 and beyond.  Our resident cosmetics

Expert Jaclyn Bellomo will take you through an introduction to the FDA’s expanded authority and regulatory power concerning Adverse Events in cosmetics. This new requirement will significantly impact how companies handle health-related consumer reports, as the FDA can request records if there is a reasonable probability of causing a serious adverse health consequence or public

With sustainability and innovation on one side and rapidly shifting consumer behavior on the other, the Beauty and Cosmetics industry is experiencing a profound transformation. Companies are working to meet these demands while also navigating evolving regulatory requirements.   This webinar will delve into the critical trends shaping the future of Beauty and Cosmetics packaging and